Key result
Heart transplantation is a treatment option for end-stage heart failure that requires rigorous evaluation of comorbidities and psychosocial variables due to a limited donor organ supply.
Heart transplantation requires rigorous evaluation of medical and psychosocial factors to optimize outcomes given the limited donor organ supply.
Underscores need for rigorous pre-transplant screening in practice; leaves open standardization of psychosocial criteria in future studies.
Heart transplantation is a treatment option available to patients with end-stage heart failure who meet standardized selection criteria for transplant. Through a rigorous evaluation process, professionals set out to establish the patient's severity of heart failure, screen for comorbidities that may negatively affect survival, and assess psychosocial variables necessary for successful outcomes following transplantation. Because of a limited donor organ supply, each of these factors must be examined carefully to assure that this scarce resource is used to its greatest potential benefit.
No takes yet. Share an insight, caveat, or question.
C. D’Amico (2005) conducted a review in End-stage heart failure. Heart transplantation was evaluated. Heart transplantation is a treatment option for end-stage heart failure that requires rigorous evaluation of comorbidities and psychosocial variables due to a limited donor organ supply.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: